Literature DB >> 29295698

Recent Updates on Computer-aided Drug Discovery: Time for a Paradigm Shift.

Talambedu Usha1, Dhivya Shanmugarajan2, Arvind Kumar Goyal3, Chinaga Suresh Kumar4, Sushil Kumar Middha2.   

Abstract

Computer-Aided Drug Designing (CADD) has gained a wide popularity among biologists and chemists as a part of interdisciplinary drug discovery approach. It plays a vital role in the discovery, design and analysis of drugs in pharmaceutical industry. It is extensively used to reduce cost, time and speed up the early stage development of biologically new active molecules. In the current review we presented a brief review of CADD, merits and demerits, DNA, protein and enzyme as targets, types of CADD: Structure Based Drug Designing (SBDD), Ligand Based Drug Designing (LBDD), Pharmacophore based drug designing (PBDD) and Fragment Based Drug Designing (FBDD), theory behind the types of CADD and their applications. The review also focuses on the in-silico pharmokinetic, pharmacodynamic and toxicity filters or predictions that play a major role in identifying the drug like molecules. Currently in pharmaceutical sciences computational tools and software are exhibiting imperative role in the different stages of drug discovery hence the review throws light on various commercial and freeware available for each step of CADD. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  CADD.; Drug discovery; Molecular dynamics; Pharmacophore; Receptor-ligand; in-silico

Mesh:

Substances:

Year:  2017        PMID: 29295698     DOI: 10.2174/1568026618666180101163651

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  9 in total

1.  Introduction to the BioChemical Library (BCL): An Application-Based Open-Source Toolkit for Integrated Cheminformatics and Machine Learning in Computer-Aided Drug Discovery.

Authors:  Benjamin P Brown; Oanh Vu; Alexander R Geanes; Sandeepkumar Kothiwale; Mariusz Butkiewicz; Edward W Lowe; Ralf Mueller; Richard Pape; Jeffrey Mendenhall; Jens Meiler
Journal:  Front Pharmacol       Date:  2022-02-21       Impact factor: 5.810

Review 2.  Latest perspectives of orally bioavailable 2,4-diarylaminopyrimidine analogues (DAAPalogues) as anaplastic lymphoma kinase inhibitors: discovery and clinical developments.

Authors:  Muhammad Latif; Zaman Ashraf; Sulman Basit; Abdul Ghaffar; Muhammad Sohail Zafar; Aamer Saeed; Sultan Ayoub Meo
Journal:  RSC Adv       Date:  2018-05-04       Impact factor: 4.036

Review 3.  Empirical Scoring Functions for Structure-Based Virtual Screening: Applications, Critical Aspects, and Challenges.

Authors:  Isabella A Guedes; Felipe S S Pereira; Laurent E Dardenne
Journal:  Front Pharmacol       Date:  2018-09-24       Impact factor: 5.810

4.  Identification of Novel Chemical Entities for Adenosine Receptor Type 2A Using Molecular Modeling Approaches.

Authors:  Kelton L B Dos Santos; Jorddy N Cruz; Luciane B Silva; Ryan S Ramos; Moysés F A Neto; Cleison C Lobato; Sirlene S B Ota; Franco H A Leite; Rosivaldo S Borges; Carlos H T P da Silva; Joaquín M Campos; Cleydson B R Santos
Journal:  Molecules       Date:  2020-03-10       Impact factor: 4.411

5.  In search of RdRp and Mpro inhibitors against SARS CoV-2: Molecular docking, molecular dynamic simulations and ADMET analysis.

Authors:  Normi D Gajjar; Tejas M Dhameliya; Gaurang B Shah
Journal:  J Mol Struct       Date:  2021-04-21       Impact factor: 3.196

6.  Targeting Cytotoxin-Associated Antigen A, a Virulent Factor of Helicobacter pylori-Associated Gastric Cancer: Structure-Based In Silico Screening of Natural Compounds.

Authors:  Shan He; Abdulraheem Ali Almalki; Misbahuddin M Rafeeq; Ziaullah M Sain; Amany I Alqosaibi; Mashael M Alnamshan; Ibtesam S Al-Dhuayan; Abdul Rahaman; Yang Zhang; Hamsa Jameel Banjer; Farah Anjum; Haitham Ali M Alzghaibi; Ali H Alharbi; Qazi Mohammad Sajid Jamal
Journal:  Molecules       Date:  2022-01-23       Impact factor: 4.411

7.  In Silico Drug Repurposing of FDA-Approved Drugs Highlighting Promacta as a Potential Inhibitor of H7N9 Influenza Virus.

Authors:  Sphamandla E Mtambo; Hezekiel M Kumalo
Journal:  Molecules       Date:  2022-07-15       Impact factor: 4.927

8.  Mechanisms of Banxia Xiexin Decoction Underlying Chronic Atrophic Gastritis via Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations.

Authors:  Cheng Chang; Weiqi Feng; Min Sun; Xiaowen Yu; Zhiguang Sun
Journal:  Comput Math Methods Med       Date:  2022-09-15       Impact factor: 2.809

Review 9.  Machine Learning Methods in Drug Discovery.

Authors:  Lauv Patel; Tripti Shukla; Xiuzhen Huang; David W Ussery; Shanzhi Wang
Journal:  Molecules       Date:  2020-11-12       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.